Top

Breast Cancer Research

Published in:

Open Access 01-12-2014 | Oral presentation

Are abnormalities missed in the PERFORMS self-assessment scheme due to visual or cognitive factors?

Authors: Y Chen, L Dong, A Gale

Published in: Breast Cancer Research | Special Issue 1/2014

Excerpt

To examine whether missed abnormalities in PERFORMS test sets are mainly due to visual or cognitive factors. …

Title: Are abnormalities missed in the PERFORMS self-assessment scheme due to visual or cognitive factors?
Authors: Y Chen
L Dong
A Gale
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Breast Cancer Research / Issue Special Issue 1/2014
Electronic ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr3700

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2014

PB.12. Audit and root-cause analysis of classification 2 and 3 interval cancers

PB.27. Breast screening with MRI in high-risk women

PB.45. Correlation of perilesional tissue stiffness measured by ultrasound strain elastography with breast density

Efficacy of second-time vacuum-assisted breast excision in the management of screen-detected high-risk breast lesions

PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI

PB.8. Ultrasound-guided excision of fibroadenomas: 9 years' experience in a British breast unit

Keynote webinar | Spotlight on antibody–drug conjugates in cancer